Navigation Links
p53, the Guardian of Our Genome

p53 is a tumor suppressor gene which was identified by Professor Sir David Lane of Dundee University in 1970.//

Experiments done on this gene using the mice model shows that the gene keeps cancer at bay and also alters the ageing process. Larry Donehower of Baylor College of Medicine in Houston created some mice without the gene and found that they later developed cancer. In another set he modified the gene and the mice were protected against cancer but aged exceptionally fast. This study proved that ageing and cancer are related and are the two sides of the same coin. This discovery raises two important and alarming questions. One, whether treatments for cancer could accelerate ageing in the patient and result in dementia, later? Secondly drugs used to prevent ageing in people increase their risk of cancer? Further research is needed to answer these questions.

Some of the facts that are known about the gene are that produces a 53,000 molecular weight protein when it is active. It is activated when it senses DNA damage. It prevents the cell from reproducing until the DNA is repaired, or it induces cell death. About 36,000 papers were published till date and bringing together every two years an ever-widening community of scientists working on the frontiers of cancer research to share their latest findings on this gene.

There is a rare condition, for instance, called Li-Fraumeni syndrome, where people are born with mutant p53 in all their cells. Affected individuals are extremely vulnerable to cancer, tending to develop tumors. p53 is kept under tight control by another gene called mdm2 that switches it on and off. Mdm2 is what stops p53 killing all our cells. Hence further research is needed to better understand the functioning of both mdm2 and p53 gene.


'"/>




Page: 1

Related medicine news :

1. Human Genome Project Achieves Technological Triumph
2. Human Diseases May Have Clue In Human-Chimp Genome Difference
3. Race Based Genome Project Launched By Mexico
4. Dog (Mans best friend) Genome Sequenced
5. Decoding the Fungi Genome Will Save Millions of Lives.
6. Yeast Genome Unravels Genes Critical For Maintaining DNA Integrity
7. Unraveling the Secrets of MHC in Human Genome
8. NHGRI Aims To Sequence Primate Genomes
9. Genome Code Cracked for Breast and Colon Cancers
10. Sea Urchin Genome Similar To Man And May Cure Diseases
11. Scientists Map Key Landmarks in Human Genome
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: the Guardian Our Genome

(Date:10/15/2008)... TomoTherapy Incorporated (NASDAQ: TOM..., recently hosted a symposium on the clinical use ...iosurgery (SRS) and stereotactic body radiation th...iArt system’s inherent suitability for stere...ty and homogeneity; presented clinical work on a v...
(Date:10/15/2008)...ct. 15 /PRNewswire-FirstCall/ -- Affiliated Comput...he award of a $27 million, 21-month,contract for t...on System,(MMIS) for the state of Alaska,s Departm... October 2007, ACS signed a $130 million, 10-year ... and operate a new MMIS system.,Now, as part of a ...
(Date:10/15/2008)...a., Oct. 15 /PRNewswire-USNewswire/ -- Clinical Ca...nnovative online, print, and live,medical educatio...ment with,the American Association for the Study o...al provider of its unique Conference Coverage of A...n San Francisco, California,October 31 - November...
(Date:10/15/2008)... to help prevent a catastrophe of epic proportions...ho Pays for Your Health Care, NEW YORK, Oct. 15 /...elling and informative. His vision of, empowering...ology,having transparent costs, and integrating s... the system from one that fails to one that...
Breaking Medicine News(10 mins):Health News: Grupo IMO Hosts Symposium on Use of TomoTherapy for Stereotactic Radiosurgery and Stereotactic Body Radiation Procedures : Experts Detail HiArt Platform Advantages for Treatment of Brain, Lung, Pancreatic and Metastatic Cancers 2Health News: Grupo IMO Hosts Symposium on Use of TomoTherapy for Stereotactic Radiosurgery and Stereotactic Body Radiation Procedures : Experts Detail HiArt Platform Advantages for Treatment of Brain, Lung, Pancreatic and Metastatic Cancers 3Health News:ACS Signs $27 Million Contract with Alaska to Transition Fiscal Agent Services for State Medicaid Program 2Health News:ACS Signs $27 Million Contract with Alaska to Transition Fiscal Agent Services for State Medicaid Program 3Health News:American Association for the Study of Liver Diseases Enters Into Agreement With Clinical Care Options as Its Authorized Online Conference Coverage Provider for the Liver Meeting(R) 2008 2Health News:With the Economy of the United States at a Turning Point, Health Care Could Be Our Next Serious Crisis ... 2
...risk of deterioration after stroke, according to a...ed in after-stroke rehabilitative therapy proved b...e likely to maintain these abilities, compared to ...go occupational therapy, the researchers found. "...
...eated with a superior method of blood stem cell tr...howed by the clinicians at the St. Jude Children's...ows blood stem cells to come from parents or unmat... aggressive, toxic treatments that usually must ac...
...but there are many effective methods to help them ...lable //— from blowing soap bubbles to teaching se...sionals do so much as that they do something, sugg...iew was to identify the best psychological interve...
...utopsy reports have shown that one –fourth of all ...curate. It's sad to note that unlike popular belie... last say regarding the cause of death of an indiv...l Confidential Enquiry into Patient Outcome and De...
Other Medicine News:Health News:Occupational Therapy Improves Independence in Stroke Survivors 2Health News:Occupational Therapy Improves Independence in Stroke Survivors 3Health News:Partial-match cell transplants for kids with resistant leukemia 2Health News:Partial-match cell transplants for kids with resistant leukemia 3Health News:Review Opens Bag of Tricks for Reducing Pain from Children’s Shot 2Health News:Review Opens Bag of Tricks for Reducing Pain from Children’s Shot 3
(Date:10/13/2008)...)-F Surface Treatment Maximizes,Endothelialization...ng-Term,Dual Antiplatelet Therapy, WASHINGTON, Oc...day,s,"Innovative Devices and Futuristic Therapies...diovascular Therapeutics (TCT) scientific,symposiu...tion, presented,12-month follow-up data from the A...
(Date:10/13/2008)...e Cancer Populations Facilitates ... 13 /- Rubicon Genomics, Inc. today,a...fy DNA samples for The,Cancer Atlas Genome Project...tandardize total genomic,DNA from 3,000 tissue and...enomePlex(TM) Whole Genome Amplification technolog...
(Date:10/12/2008)...ts designed for more uniform drug ...NGTON, Oct. 12 /- Boston,Sc... comprehensive data from,the TAXUS ATLAS clinical ...nter, single-arm, historically controlled trials, ...Eluting Stent System in a variety of,lesions and p...
(Date:10/10/2008)...wire/ -- Diplomat Specialty,Pharmacy announced tod...ecialty Pharmacy to be one of only three sites to ...imization Study for Multiple Sclerosis (TOP MS)., ...mine the benefits of a,specialty pharmacy therapy ...tient outcomes. Targeted patient outcomes will inc...
Breaking Medicine Technology:12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 212-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 312-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 4Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 2Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 3Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 2Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 3Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 4Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 5Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 6Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS) 2AARP Deeply Disappointed by Supreme Court Decision on Retiree Health Care Benefits 14970 1AARP Deeply Disappointed by Supreme Court Decision on Retiree Health Care Benefits 14970 2Cantel Medical Corp and National Safety Council Launch Joint Initiative to Prepare Businesses and Individuals for Flu Pandemic 14968 1Cantel Medical Corp and National Safety Council Launch Joint Initiative to Prepare Businesses and Individuals for Flu Pandemic 14968 2Cantel Medical Corp and National Safety Council Launch Joint Initiative to Prepare Businesses and Individuals for Flu Pandemic 14968 3WellPoints Health Plans to Cover Newly Approved Cancer Treatment 14966 1WellPoints Health Plans to Cover Newly Approved Cancer Treatment 14966 2Stress On The Campaign Trail One Issue All The Candidates Agree On 14964 1Stress On The Campaign Trail One Issue All The Candidates Agree On 14964 2
...ests are available in 14 configurations including ...g Microgenics Antibody Technology, the SureStep&tr... immunoassay targeted to detect MDMA that has an a...ity to any isomer of methamphetamine or amphetamin...
...ests are available in 14 configurations including ...g Microgenics Antibody Technology, the SureStep&tr... immunoassay targeted to detect MDMA that has an a...ity to any isomer of methamphetamine or amphetamin...
AccuSign® DOA Series Opiates Test
...ests are available in 14 configurations including ...g Microgenics Antibody Technology, the SureStep&tr... immunoassay targeted to detect MDMA that has an a...ity to any isomer of methamphetamine or amphetamin...
Medicine Products: